Claroty xDome for Healthcare was evaluated and selected by a nationally and globally recognized cancer treatment and research institution in the United States. They found their existing solution was not meeting the expectations for automating network segmentation and reducing risk, but still needed to stay within the existing budget. With Claroty xDome, a more robust set of device data and planning network segmentation was now possible.